In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections at a medical center in Taiwan: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2002-2006

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 4, 2009, Pages 317-323

  Chen, Wei Yu ^a,b   Jang, Tsrang Neng ^a   Huang, Chien Hsien ^a   Hsueh, Po Ren ^b  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Beta lactamases; Drug resistance, bacterial; Enterobacteriaceae; Infections

Indexed keywords

AMIKACIN; CIPROFLOXACIN; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; LEVOFLOXACIN;

ABDOMINAL INFECTION; ACINETOBACTER BAUMANNII; AEROMONAS HYDROPHILA; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; ENTEROBACTER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA; KLEBSIELLA PNEUMONIAE; NONHUMAN; PSEUDOMONAS AERUGINOSA; TAIWAN;

ABDOMINAL CAVITY; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GRAM-NEGATIVE AEROBIC BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS; HUMANS; INCIDENCE; MICROBIAL SENSITIVITY TESTS; POPULATION SURVEILLANCE; TAIWAN;

EID: 74849095212     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Felmingham D, Grüneberg RN. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: the Alexander Project. J Antimicrob Chemother. 1996;38(Suppl A): 1-57.
2. Pfaller MA, Jones RN, Doern GV, Kugler K. Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). Antimicrob Chemother. 1998;42:1762-70.
3. Turner PJ, Greenhalgh JM, Edwards JR, McKellar J. The MYSTIC (meropenem yearly susceptibility test information collection) programme. Int J Antimicrob Agents. 1999;13:117-25.
4. Jones RN, Masterton R. Determining the value of antimicrobial surveillance programs. Diagn Microbiol Infect Dis. 2001;41:171-5.
5. Felmingham D. The need for antimicrobial resistance surveillance. J Antimicrob Chemother. 2002;50(Suppl 1):S1-7.
6. Paterson DL, Rossi F, Baquero F, Hsueh PR, Woods GL, Satishchandran V, et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2003 Study for Monitoring Antimicrobial Resistance Trends (SMART). J Antimicrob Chemother. 2005;55:965-73.
7. Rossi F, Baquero F, Hsueh PR, Paterson DL, Bochicchio GV, Snyder TA, et al. In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring antimicrobial Resistance Trends). J Antimicrob Chemother. 2006;58:205-10.
8. Hsueh PR, Snyder TA, Dinubile MJ, Satischandran V, McCarroll K, Chow JW, et al. In vitro susceptibilities of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends). Int J Antimicrob Agents. 2006;28:238-43.
9. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed. NCCLS document, M7-A6. Villanova: National Committee for Clinical Laboratory Standards; 2003.
10. Performance standards for antimicrobial susceptibility testing. Thirteenth informational supplement. Supplemental tables M100-S13. Villanova: National Committee for Clinical Laboratory Standards; 2003.
11. Miettinen O, Nurminen M. Comparative analysis of two rates. Stat Med. 1985;4:213-26.
12. Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goos-sens H, Von Gottberg A, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30:473-8.
13. Lautenbach E, Strom BL, Bilker WB, Patel JB, Edelstein PH, Fishman NO. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Clin Infect Dis. 2001;33:1288-94.
14. Mazuski JE, Sawyer RG, Nathens AB, DiPiro JT, Schein M, Kudsk KA, et al. The Surgical Infection Society guidelines on antimicrobial therapy for intra-abdominal infections: evidence for the recommendations. Surg Infect. 2002;3:175-233.
15. Solomkin JS, Mazuski JE, Baron EJ, Sawyer RG, Nathens AB, DiPiro JT, et al. Guidelines for the selection of antinfective agents for complicated intra-abdominal infections. Clin Infect Dis. 2003;37:997-1005.
16. Hsueh PR, Hawkey PM. Consensus statement on antimicrobial therapy of intra-abdominal infections in Asia. Int J Antimicrob Agents. 2007;30:129-33.